Ingelheim, Germany, Friday, 24/10/2025 – 08 :00 CET Boehringer Ingelheim today announced new data from …
Tag:
nerandomilast
-
-
Lifestyle & Healthslider
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
by Karine Ayoubby Karine AyoubIngelheim, Germany, 13/03/2025 Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met …
-
Lifestyle & Healthslider
Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
by Karine Ayoubby Karine AyoubIngelheim, Germany, Mon, 16/09/2024 – 12:00 Boehringer Ingelheim announced today that the FIBRONEER™-IPF trial …